Skip to content
naulon
Not checkedNot checked for notices yet.

Effectiveness and safety of anticoagulant versus antiplatelet therapy in patients after endovascular revascularisation of the lower limb

Kevin Pelicon, Klemen Petek, Anja Boc and 4 more

Zdravniški Vestnik · 2022

doi:10.6016/zdravvestn.3339 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Background: After revascularisation, patients with peripheral arterial disease (PAD) are routinely prescribed antiplatelet treatment (APT). Patients who receive anticoagulant treatment (ACT) due to comorbidity are an exception. We set out to determine possible differences in the effectiveness and safety between ACT and APT in patients after endovascular revascularisation of the lower limb arteries. Methods: In a single-centre retrospective cohort study, we analysed the data of 1,587 PAD patients who underwent successful endovascular revascularisation of the lower limb arteries due to disabling intermittent claudication or chronic critical limb ischemia over a 5-year period. Patients were divided into the ACT and APT groups based on their prescribed treatment. After balancing both groups’ baseline characteristics with propensity score matching, we compared the effectiveness and safety of both treatment regimens in the first year after revascularisation. Results: Compared to patients with APT, patients with ACT were older, and more often reported arterial hypertension, diabetes, chronic kidney disease, congestive heart failure, ischaemic heart disease, and prior stroke or transient ischaemic attack. After matching, the odds ratio (OR) for an effective outcome with ACT versus APT was 0.78 (95% CI 0.39–1.59; p=0.502), while the OR for a safe outcome with ACT versus APT was 4.12 (95% CI 0.82–20.73; p=0.085). Conclusions: Patients who required ACT were elderly, had more cardiovascular risk factors and had more advanced PAD than patients with APT. After matching, we found no statistically significant difference in the effectiveness and safety of both treatment regimens; however the wide OR confidence intervals warrant further research.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.